ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag hiv art quotes innovation

Top 10 Innovations 2016
The Scientist | Dec 1, 2016 | 10+ min read
This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.
The Optical Trap
Don Monroe | Aug 28, 2005 | 8 min read
When Art Ashkin, Steve Chu, and their colleagues at Bell Labs in Holmdel, NJ, first invented optical tweezers, they spent their days pushing around tiny, glass spheres.
Genome Investigator Craig Venter Reflects On Turbulent Past And Future Ambitions
Karen Young Kreeger | Jul 23, 1995 | 8 min read
And Future Ambitions Editor's Note: For the past four years, former National Institutes of Health researcher J. Craig Venter has been a major figure in the turbulent debates and scientific discoveries surrounding the study of genes and genomes. Events heated up in 1991, when NIH attempted to patent gene fragments, which were isolated using Venter's expressed sequence tag (EST)/complementary DNA (cDNA) approach for discovering human genes (M.A. Adams et al., Science, 252:1651-6, 1991). NIH's mo
artificial intelligence image data learning
Artificial Intelligence Sees More in Microscopy than Humans Do
Jef Akst | May 1, 2019 | 8 min read
Deep learning approaches in development by big players in the tech industry can be used by biologists to extract more information from the images they create.
AIDS Researchers, Activists Wary Of Newspaper Article's Message
Steven Benowitz | Jun 9, 1996 | 10+ min read
Despite contrary suggestions, they say CDC's prevention efforts aimed toward general public were not wasted A recent article in the Wall Street Journal is causing concern in the AIDS research community. The article, titled "AIDS Fight Is Skewed By Federal Campaign Exaggerating Risks" (A. Bennett, A. Sharpe, May 1, 1996, page 1), contends that the federal Centers for Disease Control and Prevention (CDC) in Atlanta has distorted the public's perception of the potential for contracting AIDS with a
The Little Cell That Could
Megan Scudellari | Jul 1, 2012 | 7 min read
Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.
Notebook
The Scientist Staff | Mar 2, 1997 | 8 min read
Monday mornings can be tough, even if you're Bill Gates. The head of Redmond, Wash.-based Microsoft Corp. ran into a few glitches at a presentation he was giving at the annual meeting of the American Association for the Advancement of Science (AAAS) in Seattle. In the middle of a demonstration on February 17 aimed at showing how Web browsers and E-mail will soon merge, the modem connection failed. A computer-vision demonstration by a Microsoft researcher didn't work, either. Then, during a ques
All's Well that Ends Well: A Profile of Specialty Microwell Plates
Brent Johnson | Sep 26, 1999 | 10+ min read
Date: September 27, 1999Table of Specialty Microplates The story of the microplate is one of those tales of history that either has been forgotten or was never clearly understood. According to Barry Lazar of Dynex Technologies, formerly Dynatech Laboratories, the origin of what is now commonly referred to by Dynex's registered trademark of Microtiter plates began with Gyola Takatsy, a Hungarian-born scientist who was trying to scale down serology tests. His first prototype became available in 1
Today's Lab
Laura Defrancesco | Mar 3, 2002 | 8 min read
Tom Sargent remembers the day a student in his lab forgot to add boiling chips to phenol before firing up the heater on the distillation apparatus, and the panicked shouting and tearing off of the lab coat, goggles, gloves, and shoes that ensued when the phenol superheated and boiled over. "Fortunately he wasn't hurt," said Sargent, now chief of the section on vertebrate development at the National Institute of Child and Human Development, "but what a mess." Then, there was the time he hooked up

Run a Search

ADVERTISEMENT